SAFETY ASPECTS OF GH THERAPY IN TURNER SYNDROME (TS): NO EVIDENCE FOR VENTRICULAR HYPERTROPHY (VH) AND NORMALIZATION OF INSULIN LEVELS AFTER DISCONTINUATION OF GH. 572

SAFETY ASPECTS OF GH THERAPY IN TURNER SYNDROME (TS): NO EVIDENCE FOR VENTRICULAR HYPERTROPHY (VH) AND NORMALIZATION OF INSULIN LEVELS AFTER DISCONTINUATION OF GH. 572